HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parfums Caron

This article was originally published in The Rose Sheet

Executive Summary

Lady Caron women's scent bows in April as "an homage to America." Commemorating founder Ernest Daltroff's 1939 Ellis Island landing, the scent's clear glass bottle is embossed with the face of the Statue of Liberty, while the outer carton features a sepia photo of the statue with messages of hope as a background. The floral juice opens with top notes of magnolia, jasmine and neroli, leading to a heart of rose, raspberry and peach. A woody base is built around oakmoss and sandalwood. Prices range from $80 for a 1.7 oz. edp spray to $150 for a .5 oz. perfume extract. The fragrance will be sold in select Saks Fifth Avenue and Nordstrom doors as well as the Caron Boutique, scheduled to open in Manhattan in the spring. A limited edition Baccarat bottle for Lady Caron will be unveiled at the boutique's opening

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel